BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21278791)

  • 1. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
    Colombo E; Alcalay M; Pelicci PG
    Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
    Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
    FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin may act as an alarmin: implications for severe sepsis.
    Nawa Y; Kawahara K; Tancharoen S; Meng X; Sameshima H; Ito T; Masuda Y; Imaizumi H; Hashiguchi T; Maruyama I
    J Leukoc Biol; 2009 Sep; 86(3):645-53. PubMed ID: 19581374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin: a versatile molecule associated with hematological malignancies.
    Naoe T; Suzuki T; Kiyoi H; Urano T
    Cancer Sci; 2006 Oct; 97(10):963-9. PubMed ID: 16984370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleophosmin regulates the stability and transcriptional activity of p53.
    Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
    Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophosmin and human cancer.
    Lim MJ; Wang XW
    Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nucleophosmin in embryonic development and tumorigenesis.
    Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
    Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones.
    Frehlick LJ; Eirín-López JM; Ausió J
    Bioessays; 2007 Jan; 29(1):49-59. PubMed ID: 17187372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
    Weng CH; Yung BY; Weng JJ; Wu MH
    J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nucleophosmin in centrosome duplication.
    Okuda M
    Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
    Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
    Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleophosmin is overexpressed in thyroid tumors.
    Pianta A; Puppin C; Franzoni A; Fabbro D; Di Loreto C; Bulotta S; Deganuto M; Paron I; Tell G; Puxeddu E; Filetti S; Russo D; Damante G
    Biochem Biophys Res Commun; 2010 Jul; 397(3):499-504. PubMed ID: 20515654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nucleophosmin mutations in hematological malignancies - review].
    Luo ZP; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
    Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
    J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.
    Tarapore P; Shinmura K; Suzuki H; Tokuyama Y; Kim SH; Mayeda A; Fukasawa K
    FEBS Lett; 2006 Jan; 580(2):399-409. PubMed ID: 16376875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation.
    Lindström MS; Zhang Y
    J Biol Chem; 2008 Jun; 283(23):15568-76. PubMed ID: 18420587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.